For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest transparency reporting regulations and HCP/O engagement rules. As a leading provider of transparency reporting solutions, MediSpend also offers our complementary Legislative Watch to help keep you up-to-date on related legislation.
MediSpend’s Legislative Watch puts the information you need at your fingertips. Let our experts help keep you informed of important changes.
To learn more, please provide us your information to access the MediSpend webinar “Legislative Watch Update”. In this webinar, our experts provide viewers with updates on transparency reporting and HCP engagement regulations in the United States and globally. Highlights include:
US updates:
- CMS Open Payments
- 2022 Medicare Physician Fee Schedule Final Rule
- Nevada Pharmaceutical Rep Disclosure
- Oregon Pharmaceutical Rep Licensure & Disclosure
OUS updates:
- France Loi Bertrand
- Saudia Arabia
- United Kingdom
- Chile
- Ireland
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.